Key result
A 23-year-old male with thyrotoxic periodic paralysis developed refractory ventricular fibrillation and cardiogenic shock, successfully bridged to recovery using ECMO despite ischemic complications.
Why the study?
Progression of thyrotoxic periodic paralysis to thyroid storm with life-threatening arrhythmias and multiorgan failure is exceedingly rare.
Case Report (n=1)
Early ECMO support can serve as a vital bridge to recovery in patients with refractory thyrotoxic arrhythmias and cardiogenic shock, though it carries significant risks of limb-threatening ischemia.
May support ECMO in refractory shock from thyrotoxic periodic paralysis; leaves open need for systematic safety and efficacy data.
Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism, often seen in young males, characterized by acute flaccid paralysis due to intracellular potassium shifts. While most cases present with isolated muscle weakness, progression to thyroid storm with life-threatening arrhythmias and multiorgan failure is exceedingly rare. We present the case of a previously healthy 23-year-old male who arrived with profound weakness and was found to have severe hypokalemia and suppressed thyroid-stimulating hormone (TSH). Shortly after arrival, he developed ventricular fibrillation and suffered prolonged cardiac arrest, requiring nearly 90 minutes of cardiopulmonary resuscitation. He was placed on extracorporeal membrane oxygenation (ECMO) for refractory cardiogenic shock. His hospital course was further complicated by rhabdomyolysis, acute kidney injury requiring renal replacement therapy, and distal limb ischemia due to femoral cannulation, ultimately necessitating left above-knee amputation and right upper extremity fasciotomy. This case highlights the catastrophic potential of TPP and thyroid storm, the role of early ECMO support in refractory thyrotoxic arrhythmias, and the vascular risks associated with peripheral ECMO cannulation in the critically ill. Prompt recognition and aggressive support remain the cornerstone of survival in endocrine-driven cardiopulmonary collapse.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2025) conducted a case report in Thyrotoxic periodic paralysis with cardiogenic shock (n=1). Extracorporeal membrane oxygenation (ECMO) was evaluated. A 23-year-old male with thyrotoxic periodic paralysis developed refractory ventricular fibrillation and cardiogenic shock, successfully bridged to recovery using ECMO despite ischemic complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: